With his extensive knowledge of the life sciences, including industry and university research in the life sciences and more than 20 years of experience in intellectual property law, David M. Saravitz, Ph.D., helps his clients develop, protect, and manage their intellectual property assets.

Dr. Saravitz has extensive experience in worldwide patent procurement and has helped clients obtain patents on their inventions in countries in North America, South America, Europe, Asia, Australia and Africa.  He also has experience in general patent counseling, strategic planning, patent licensing, IP-related due diligence in business transactions, and patent-related opinions, including freedom to operate, non-infringement, invalidity and patentability.

In addition to earning a J.D. from the North Carolina Central University School of Law, Dr. Saravitz’s background includes a Ph.D. in cell and molecular biology from Duke University, an M.S. from North Carolina State University and a B.S., with distinction, from The Pennsylvania State University. At law school, he served as chair of the Intellectual Property Law Society. While studying at Duke, Dr. Saravitz was the recipient of both a National Institutes of Health Cell and Molecular Biology Training Grant and a Plant Molecular Biology Fellowship from the North Carolina Biotechnology Center. He currently serves on the Commercialization Advisory Panel for the Biotechnology Innovation Grant program at the North Carolina Biotechnology Center.

Dr. Saravitz is also a co-inventor of U.S. Patent No. 6,284,711 and its corresponding patents in Argentina, Australia, Brazil, Canada, China, Eurasia, Europe, Mexico, New Zealand, South Korea, and South Africa.